HeartBeam holders back board, reject share plan increase
HeartBeam, Inc. reported the results of its July 31, 2026 annual stockholder meeting held via live webcast.
Rhea-AI Filing Summary
HeartBeam, Inc. reported the results of its July 31, 2026 annual stockholder meeting held via live webcast. As of the June 5, 2026 record date, 55,506,835 shares of common stock were outstanding and entitled to vote, and 29,050,272 votes, or 52.34% of outstanding votes, were represented, constituting a quorum.
Stockholders elected all seven director nominees to one-year terms, with each receiving over 10 million votes in favor and approximately 0.9–1.3 million votes against, plus broker non-votes. They also approved the ratification of CBIZ CPAs P.C. as independent registered public accounting firm for the year ending December 31, 2026, with 28,612,850 votes for and 173,008 against.
A proposal to amend the 2022 Equity Incentive Plan to increase authorized shares by 3,000,000 shares did not receive stockholder approval, drawing 3,957,529 votes for, 7,816,794 against, 41,929 abstentions and 17,234,020 broker non-votes.
Positive
- None.
Negative
- None.
Filing Explained
At the July 31 annual meeting, stockholders rejected the proposed increase of
8-K Event Classification
Key Figures
Key Terms
broker non-votes regulatory
independent registered public accounting firm regulatory
Equity Incentive Plan financial
record date regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the quorum and voting participation at HeartBeam (BEAT)’s 2026 annual meeting?
Were HeartBeam (BEAT)’s director nominees elected at the July 31, 2026 annual meeting?
Did HeartBeam (BEAT) stockholders approve the company’s independent auditor for 2026?
What are broker non-votes reported in HeartBeam (BEAT)’s 2026 annual meeting results?
AI-generated analysis. How Rhea-AI works. Not financial advice.